docturnal Company
Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones. The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile. Docturnal was established in April 2016.
Technology:
Сancer Diagnostics
Industry:
P4 Medicine
Headquarters:
Hyderabad, Andhra Pradesh, India
Zip:
1-10
Founded Date:
2016-04-01
Employees Number:
1-10
Funding Status:
Seed
Acquisitions Number:
7
Investors Number:
147425
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
info@docturnal.com
Register and Claim Ownership